Zürich (ots) - Der Verein Campaigning Summit Switzerland erhält den eidgenössischen Ritterschlag ...
Medify Solutions Limited Announces Dividend
Stafford, England, November 22 (ots/PRNewswire) - Medify Solutions Limited (OTC - MDFY), today announced that due to the achievement of major performance milestones and the positive circumstances created by the significant NHS developments, the company is issuing a 1 for 4 (25%) share dividend. This is also in recognition by the board that the activities announced to shareholders in June 2006 relating to subsidiary floatation (and associated dividend) are currently suspended. The subsidiary floatation status is unchanged from the most recently issued Quarterly Report.
The dividend is valid for all individuals holding shares in MDFY.pk as per the Medify Solutions Limited Shareholders of record at 5pm Eastern Standard Time on the 30th November 2006. The dividend will be paid in MDFY.pk shares, (electronically if available for shareholders trading accounts), viathe company transfer agent, Fidelity Transfer on the 15th December 2006.
To clarify, for every 4 shares held by a shareholder at 5pm 30th November2006, a dividend of 1 share will be issued (by the Company) to that shareholder on 15th December 2006.
It is the decision of the Board that the restricted stock issued to the management team during September 2006 will not be eligible for this dividend.
Ian O'Reilly, CEO of Medify Solutions, Ltd., commented to shareholders: "given the major step changes we are seeing in the business and the impending announcements from the NHS, the board feels that this course of action is the correct response to our shareholders who continue to invest in the Company".
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate", "project", "intends", "expects", "believes", and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch
For further information: Press Office email:
email@example.com; General email:
firstname.lastname@example.org; Fidelity Transfer: +1-801-484-7222;
More information at: www.medifysolutions.com